Source: BioPortfolio

Thar Pharmaceuticals: BRIEFThar Pharmaceuticals files for IPO of up to $50 million

Applied to have common stock listed on the Nasdaq GlobalMarket under the trading symbol "THAR" SEC filingSource text for Eikon

Read full article »
Thar Pharmaceuticals's Competitors | Thar Pharmaceuticals's News | Thar Pharmaceuticals's Financials
Stay up-to-date with the latest news on Thar Pharmaceuticals
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Raymond K. Houck's photo - President & CEO of Thar Pharmaceuticals

President & CEO

Raymond K. Houck

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Thar Pharmaceuticals